Introduction: Who Should Undergo Diagnostics

Genitourinary syndrome of menopause is a condition that develops when the body produces less estrogen, a hormone that helps maintain healthy tissues in the vaginal and urinary areas. Most women going through or past menopause will experience some symptoms of this condition, yet many do not realize that what they are experiencing has a name or that help is available. Understanding when to seek diagnostic testing is the first step toward finding relief from uncomfortable symptoms that can affect daily life, relationships, and overall well-being.^[1]

Women should consider seeking diagnostics if they notice changes in their vaginal health or urinary function, particularly during or after menopause. The most common reason women first visit their doctor is vaginal dryness, which often becomes noticeable during sexual activity. However, this is just one of many possible signs. If you experience burning, itching, or irritation in the vaginal area, painful urination, or find yourself needing to urinate more frequently than before, these could all be indicators that diagnostic evaluation would be helpful.^[4]

It is especially important to seek medical attention if you notice any unexplained vaginal spotting or bleeding, unusual discharge, or if sexual intercourse has become painful and over-the-counter lubricants or moisturizers are not providing adequate relief. Many women feel embarrassed to discuss these symptoms with their healthcare provider, but doctors recommend that all women going through perimenopause and menopause should be screened for genitourinary syndrome of menopause as part of their routine care.^[4][15]

While genitourinary syndrome of menopause primarily affects postmenopausal women, it can also develop in younger women whose estrogen levels have dropped for other reasons. Women who have recently given birth, are breastfeeding, have undergone cancer treatments such as chemotherapy or radiation, have had their ovaries surgically removed, or use certain medications that reduce estrogen may also develop symptoms. Even some women who use long-term oral contraception can experience signs of this condition. If you fall into any of these categories and notice vaginal or urinary symptoms, seeking diagnostic evaluation is advisable regardless of your age.^[7][13]

Diagnostic Methods

Diagnosing genitourinary syndrome of menopause typically begins with a conversation between you and your healthcare provider. The most important first step is for your doctor to ask appropriate questions about your symptoms during your medical history. They should inquire about vaginal dryness, burning, itching, pain during sexual activity, changes in urination patterns, and how often you experience urinary tract infections. Many doctors now incorporate vaginal health screening into routine appointments, such as during regular gynecological visits for women aged 45 to 69 years.^[11][15]

After discussing your symptoms, your doctor will typically perform a physical examination. The pelvic exam is a key diagnostic tool where the healthcare provider visually examines your external genitals, vagina, and cervix. During this examination, they look for specific physical signs that indicate genitourinary syndrome of menopause. These signs might include thinning of the vaginal walls, loss of the natural folds or ridges inside the vagina called rugae, decreased moisture, paleness of the vaginal tissue, reduced elasticity, and narrowing of the vaginal opening. The provider may also check for thinning or graying of pubic hair and examine the urethral area for any unusual growths or changes.^[12][8]

During the pelvic examination, your healthcare provider will also gently press on your abdomen while inserting two gloved fingers into your vagina. This allows them to examine your uterus, ovaries, and other pelvic organs to ensure there are no other conditions that might be causing your symptoms. The examination helps distinguish genitourinary syndrome of menopause from other conditions that can cause similar symptoms.^[12]

One important diagnostic test that may be performed is the acid balance test, also called a vaginal pH test. This involves taking a small sample of vaginal fluid or placing a special paper indicator strip in your vagina to measure its acidity level. When estrogen levels are normal, the vagina maintains a slightly acidic environment, typically with a pH below 5. However, when estrogen drops, the vaginal pH increases above 5, creating an environment that is less protective against infections. Finding an elevated vaginal pH is a supportive finding that helps confirm the diagnosis of genitourinary syndrome of menopause.^[5][12]

If you are experiencing urinary symptoms such as painful urination, your doctor may order a urine test or urinalysis. This test helps distinguish between genitourinary syndrome of menopause and a urinary tract infection, as both conditions can cause discomfort when urinating. A urinary tract infection is diagnosed when the urine test shows inflammation and infection due to abnormal bacterial growth. In contrast, with genitourinary syndrome of menopause, the burning sensation occurs when urine touches the thin, sensitive vaginal tissue rather than from an actual infection in the urinary tract.^[1][9]

In some cases, your doctor might examine vaginal fluid samples under a microscope. They look at what is called the maturation index, which shows the types of cells present in the vaginal lining. With genitourinary syndrome of menopause, there is typically an increase in parabasal cells, which are immature cells found in the deeper layers of tissue, and a decrease in superficial cells, which are the mature cells normally found on the surface of healthy vaginal tissue. This cellular pattern supports the diagnosis by showing that the vaginal tissue has become thinner and less mature due to lack of estrogen.^[5]

Your healthcare provider will also work to rule out other conditions that might cause similar symptoms. They need to distinguish genitourinary syndrome of menopause from overactive bladder, for example. While symptoms can overlap between these conditions, women with overactive bladder tend to experience more urinary incontinence symptoms on their own, whereas women with genitourinary syndrome of menopause typically experience both vaginal and urinary symptoms together. The combination of vaginal dryness along with urinary urgency or frequency is more characteristic of genitourinary syndrome of menopause.^[1][9]

It is worth noting that while the American Urological Association has published guidelines for genitourinary syndrome of menopause, there is currently no universally agreed-upon checklist of symptoms required for diagnosis. This means that experienced healthcare providers use a combination of your reported symptoms, physical examination findings, and test results to make an accurate diagnosis. The diagnosis is primarily clinical, meaning it relies heavily on recognizing the pattern of symptoms and physical changes rather than on a single definitive test.^[7][13]

Diagnostics for Clinical Trial Qualification

When women with genitourinary syndrome of menopause are being considered for participation in clinical trials, additional or more standardized diagnostic criteria may be applied. Clinical trials need to ensure that all participants truly have the condition being studied and that their symptoms are measured consistently across all study sites and participants. This helps researchers accurately evaluate whether new treatments are working.

For clinical trial enrollment, researchers typically look for a combination of both symptoms and objective signs that can be measured. The symptoms that qualify someone for many genitourinary syndrome of menopause trials include vaginal symptoms such as dryness, burning, and irritation; sexual symptoms including lack of lubrication, discomfort or pain during intercourse, and impaired sexual function; and urinary symptoms like urgency, painful urination, and recurrent urinary tract infections. Participants usually need to report that these symptoms are bothersome enough to affect their quality of life.^[5]

In addition to symptoms, clinical trials often require objective, measurable signs to confirm the diagnosis. One standard criterion is a vaginal pH measurement greater than 5, which indicates the loss of the normal acidic vaginal environment that estrogen helps maintain. Another common requirement is specific findings on microscopic examination of vaginal cells. Researchers look for decreased superficial cells on a wet mount preparation or maturation index, showing that the vaginal lining has become thinner and contains fewer mature cells. Some studies may also look for increased parabasal cells, which are the immature cells that become more prominent when estrogen levels are low.^[5]

Clinical trials may also use more detailed questionnaires or scales to measure the severity and impact of symptoms. These standardized assessment tools help researchers track whether symptoms improve during the study and allow comparison between different treatment approaches. Some trials might include quality-of-life assessments that measure how symptoms affect sexual relationships, emotional well-being, and daily activities.

Physical examination findings documented for clinical trial purposes often include detailed descriptions of vaginal tissue appearance, such as the degree of paleness, loss of tissue folds, presence of small tears or abrasions, and measurement of vaginal narrowing or shortening. Some research studies might use specialized equipment to more precisely measure tissue thickness or moisture levels, though these are not typically part of routine clinical diagnosis outside of research settings.